Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7 Thoracic 6 Tumor-Agnostic 4 Genitourinary 4 CNS 3 Plasma cell 1 Other 1 Lymphoid 1 Gynecologic 1 Dermatologic 1 Breast 1

Conditions

Uveal Melanoma 1

Interventions

pembrolizumab 156 Nivolumab 131 Ipilimumab 76 Cyclophosphamide 46 Specimen Handling 44 Magnetic Resonance Spectroscopy 39 cemiplimab 35 Biopsy 31 fludarabine 28 trametinib 24 relatlimab 24 binimetinib 23 Interleukin-2 21 fludarabine phosphate 20 dabrafenib 20 atezolizumab 20 Radiotherapy 19 Opdualag 19 Radiosurgery 18 encorafenib 17 aldesleukin 17 CTLA-4 Antigen 17 Blood Specimen Collection 17 avelumab 14 Immunoglobulin G 14 Disulfides 13 lenvatinib 11 Bevacizumab 11 lifileucel 10 Paclitaxel 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hematologic Tests × Dermatologic × 1 year × Clear all

NCT04424719 2025-09-03

SALOME

Institut Curie

Phase NA Recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡